These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 22932266

  • 1. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
    Zhang C, Wang C, Feng W.
    Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
    [Abstract] [Full Text] [Related]

  • 2. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M, Nogawa T, Matsumoto T, Yokoyama T, Shiroyama Y, Wroblewski J.
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [Abstract] [Full Text] [Related]

  • 3. Lymphovascular space involvement is the sole independent predictor of lymph node metastasis in clinical early stage endometrial cancer.
    Vaizoglu F, Yuce K, Salman MC, Basaran D, Calis P, Ozgul N, Usubutun A.
    Arch Gynecol Obstet; 2013 Dec; 288(6):1391-7. PubMed ID: 23764931
    [Abstract] [Full Text] [Related]

  • 4. Predicting pelvic lymph node metastasis in endometrial carcinoma.
    Kamura T, Yahata H, Shigematsu T, Ogawa S, Amada S, Kaku T, Nakano H.
    Gynecol Oncol; 1999 Mar; 72(3):387-91. PubMed ID: 10053111
    [Abstract] [Full Text] [Related]

  • 5. Is Surgical Staging Necessary for Patients with Low-risk Endometrial Cancer? A Retrospective Clinical Analysis.
    Kokcu A, Kurtoglu E, Celik H, Kefeli M, Tosun M, Onal M.
    Asian Pac J Cancer Prev; 2015 Mar; 16(13):5331-5. PubMed ID: 26225674
    [Abstract] [Full Text] [Related]

  • 6. Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.
    Hahn HS, Lee IH, Kim TJ, Lee KH, Shim JU, Kim JW, Lim KT.
    Aust N Z J Obstet Gynaecol; 2013 Jun; 53(3):293-7. PubMed ID: 23600915
    [Abstract] [Full Text] [Related]

  • 7. The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
    Akbayir O, Corbacioglu A, Goksedef BP, Numanoglu C, Akca A, Guraslan H, Bakir LV, Cetin A.
    Gynecol Oncol; 2012 May; 125(2):400-3. PubMed ID: 22310644
    [Abstract] [Full Text] [Related]

  • 8. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K, Umayahara K, Abe A, Usami T, Yamamoto A, Nomura H, Matoda M, Okamoto S, Omatsu K, Kondo E, Kato K, Takeshima N.
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [Abstract] [Full Text] [Related]

  • 9. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [Abstract] [Full Text] [Related]

  • 10. Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.
    Odagiri T, Watari H, Kato T, Mitamura T, Hosaka M, Sudo S, Takeda M, Kobayashi N, Dong P, Todo Y, Kudo M, Sakuragi N.
    Ann Surg Oncol; 2014 Aug; 21(8):2755-61. PubMed ID: 24705578
    [Abstract] [Full Text] [Related]

  • 11. Para-aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis.
    Baiocchi G, Faloppa CC, Mantoan H, Camarço WR, Badiglian-Filho L, Kumagai LY, De Brot L, da Costa AABA.
    J Surg Oncol; 2017 Aug; 116(2):220-226. PubMed ID: 28482122
    [Abstract] [Full Text] [Related]

  • 12. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers.
    Yokoyama Y, Maruyama H, Sato S, Saito Y.
    Gynecol Oncol; 1997 Mar; 64(3):411-7. PubMed ID: 9062142
    [Abstract] [Full Text] [Related]

  • 13. Risk factors for paraaortic lymph node metastasis in endometrial cancer.
    Sari ME, Yalcin İ, Sahin H, Meydanli MM, Gungor T.
    Int J Clin Oncol; 2017 Oct; 22(5):937-944. PubMed ID: 28523533
    [Abstract] [Full Text] [Related]

  • 14. Is it possible to predict para-aortic lymph node metastasis in endometrial cancer?
    Turan T, Hizli D, Sarici S, Boran N, Gundogdu B, Karadag B, Tulunay G, Kose MF.
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):274-9. PubMed ID: 21664758
    [Abstract] [Full Text] [Related]

  • 15. Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer.
    Fujimoto T, Nanjyo H, Nakamura A, Yokoyama Y, Takano T, Shoji T, Nakahara K, Yamada H, Mizunuma H, Yaegashi N, Sugiyama T, Kurachi H, Sato A, Tanaka T.
    Gynecol Oncol; 2007 Nov; 107(2):253-9. PubMed ID: 17640720
    [Abstract] [Full Text] [Related]

  • 16. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, Oikawa M, Yamamoto R, Yamada H, Fujimoto S.
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [Abstract] [Full Text] [Related]

  • 17. The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasis.
    Dogan Altunpulluk M, Kir G, Topal CS, Cetiner H, Gocmen A.
    J Obstet Gynaecol; 2015 May; 35(4):397-402. PubMed ID: 25279582
    [Abstract] [Full Text] [Related]

  • 18. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
    Pollom EL, Conklin CM, von Eyben R, Folkins AK, Kidd EA.
    Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathological factors predicting retroperitoneal lymph node metastasis and survival in endometrial cancer.
    Tang X, Tanemura K, Ye W, Ohmi K, Tsunematsu R, Yamada T, Katsumata N, Sonoda T.
    Jpn J Clin Oncol; 1998 Nov; 28(11):673-8. PubMed ID: 9861234
    [Abstract] [Full Text] [Related]

  • 20. Risk factors predictive of para-aortic lymph node metastasis in endometrial carcinomas.
    Yokoyama Y, Maruyama H, Sato S, Saito Y.
    J Obstet Gynaecol Res; 1997 Apr; 23(2):179-87. PubMed ID: 9158306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.